Ancora Advisors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.4M Buy
409,267
+238,798
+140% +$2.47M 0.07% 215
2025
Q4
$2.11M Buy
+170,469
New +$1.83M 0.04% 295
2021
Q4
Sell
-80
Closed -$4K 2392
2021
Q3
$4K Sell
80
-90
-53% -$5.45K ﹤0.01% 1952
2021
Q2
$11K Sell
170
-540
-76% -$34.7K ﹤0.01% 1504
2021
Q1
$66K Sell
710
-27,309
-97% -$2.8M ﹤0.01% 979
2020
Q4
$2.51M Buy
28,019
+10,210
+57% +$937K 0.08% 231
2020
Q3
$1.84M Sell
17,809
-14,199
-44% -$1.53M 0.07% 233
2020
Q2
$2.53M Buy
32,008
+11,590
+57% +$864K 0.11% 195
2020
Q1
$1.18M Buy
20,418
+6,788
+50% +$391K 0.06% 297
2019
Q4
$735K Buy
13,630
+330
+2% +$17.9K 0.03% 438
2019
Q3
$695K Buy
+13,300
New +$620K 0.03% 398

Other funds holding EBS